Kari Stoever is a global health and development expert. She is the Vice President of External Affairs at Aeras - a global nonprofit biotech advancing TB vaccines for the world. Formerlly she was the President and Founder of Meliora Global, LLC a team that accelerates business growth and provides solutions to complex social issues by connecting clients to unique global network of financial, health and strategic partners. She has more than 15 years of experience leading all aspects of nonprofit and research initiatives. In her previous role at the Sabin Vaccine Institute, she helped establish and was the Managing Director of the Global Network for Neglected Tropical Diseases. She was the Principal Investigator on a $34 million grant by the Bill & Melinda Gates Foundation to establish regional financing mechanisms and to increase international investments for the scale-up of NTD control and elimination strategies globally. Under her leadership, the Global Network secured more than US $86 million in grants and financial commitments. She has been active in the Clinton Global Initiative since its inception and has made key contacts with policy makers and opinion leaders in the United States, Europe, Latin America, and Africa. Prior to her work at Sabin, she spent several years managing clinical research studies in cancer and infectious diseases. She spent a year working for the Department of Defense at the United States Army Medical Research Institute for infectious diseases (USAMRIID) managing anthrax and other biodefense studies. She is a board member on the Women’s Leadership Initiative at Georgetown University’s McDonough School of Business and of Rwanda Works. She holds a B.Sc. from George Washington University, a degree in nursing, and an Executive Masters in Leadership from the McDonough School of Business, Georgetown University. In 2009 she participated in Fortune’s Most Powerful Women Summit.